Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenues:
Total revenues	$ 166,140	$ 186,198	$ 582,843	$ 548,615
Cost of revenues	(129,440)	(166,265)	(414,957)	(492,942)
Gross profit	36,700	19,933	167,886	55,673
Operating expenses:
Research and development	1,791,695	2,237,565	5,586,302	5,483,695
General and administrative	1,326,249	1,147,279	5,250,510	3,159,155
Total operating expenses	3,117,944	3,384,844	10,836,812	8,642,850
Loss from operations	(3,081,244)	(3,364,911)	(10,668,926)	(8,587,177)
Other income (expense):
Gain on forgiveness of PPP loan				421,584
Foreign currency transaction (loss)/gain	(12,613)	(66,967)	(26,006)	(22,384)
Interest expense, net	(215,146)	(227,271)	(641,768)	(676,512)
Research and development incentives		40,844	136,981	121,896
Other income (expense)		30,754		30,754
Total other income (expense)	(227,759)	(222,640)	(530,793)	(124,662)
Net loss before income taxes	(3,309,003)	(3,587,551)	(11,199,719)	(8,711,839)
Income tax benefit	1,154,935	864,742	1,154,935	864,742
Net loss applicable to common stockholders	$ (3,309,003)	$ (3,587,551)	$ (10,044,784)	$ (7,847,097)
Basic net loss per share (in Dollars per share)	$ (0.08)	$ (0.09)	$ (0.23)	$ (0.20)
Diluted net loss per share (in Dollars per share)	$ (0.08)	$ (0.09)	$ (0.23)	$ (0.20)
Basic weighted average common shares outstanding (in Shares)	43,083,690	40,697,888	43,005,912	39,210,984
Diluted weighted average common shares outstanding (in Shares)	43,083,690	40,697,888	43,005,912	39,210,984
Licensing revenue
Revenues:
Revenues			$ 50,000
Contract revenue
Revenues:
Other revenue				$ 33,351
Grant revenue
Revenues:
Other revenue	$ 166,140	$ 186,198	$ 532,843	$ 515,264